Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
Mild cognitive impairment, a common brain condition, can be an early sign of Alzheimer's disease. But most people don't know the symptoms. And some may mistake it for normal aging.
Novelist Amy Bloom talks about how, at her husband's insistence, she traveled with him to Zurich so he could legally terminate his life. Her new memoir is In Love.
Arts therapies appear to ease brain disorders from Parkinson's to PTSD. Now, artists and scientists have launched an effort to understand how these treatments change the brain.
Microglia are amoeba-like cells that scour the brain for injuries and invaders. But sometimes the usually helpful cells go into overdrive and damage the brain, researchers say.
A new Alzheimer's drug isn't reaching many patients. Doctors say reasons include its high cost, and lingering questions about its effectiveness.
Scientists have created detailed maps of the brain area that controls movement in mice, monkeys and people. The maps could help explain human ailments like Alzheimer's and Lou Gehrig's disease.
Weeks after the Food and Drug Administration approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.
The FDA has until Monday to decide whether to approve the first new Alzheimer's drug in nearly two decades. Two big studies of the drug produced conflicting results.
The two officers involved in the violent arrest that attorneys say left Karen Garner with a dislocated shoulder were criminally charged on Wednesday.